Stock Events

Stock Events

WPD Pharmaceuticals 

C$0.070000
4
-C$0.12-63.16%Thursday 19:09

Statistics

Day High
0.07
Day Low
0.07
52W High
0.07
52W Low
0.07
Volume
0
Avg. Volume
0
Mkt Cap
8.12M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Nov 29Expected
Q3 2021
-0.01
0.33
0.66
0.99
Expected EPS
N/A
Actual EPS
-0.0062

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-80,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap368.89B
Merck & Co., Inc. is a global healthcare company that develops medications in oncology, similar to WPD Pharmaceuticals' focus on cancer-related therapies.
Pfizer
PFE
Mkt Cap173.95B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including cancer drugs, directly competing in the same therapeutic areas as WPD Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol-Myers Squibb Company specializes in biopharmaceutical products, including a strong portfolio in cancer treatments, overlapping with WPD Pharmaceuticals' market.
Novartis
NVS
Mkt Cap303.67B
Novartis AG is known for its innovative medicines in various disease areas including oncology, competing with WPD Pharmaceuticals in cancer drug development.
Lilly(Eli) &
LLY
Mkt Cap1.26T
Eli Lilly and Company focuses on pharmaceuticals including cancer treatments, making it a direct competitor in the oncology sector.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc. develops and markets drugs for life-threatening diseases including cancer, positioning it as a competitor in the oncology field.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. is a biotech company focusing on human therapeutics, with a significant presence in oncology, competing with WPD Pharmaceuticals.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca PLC is a biopharmaceutical company with a strong emphasis on the development of cancer treatments, directly competing with WPD Pharmaceuticals.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, including cancer drugs, making it a key competitor in the oncology market.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson engages in the research and development of pharmaceuticals, including oncology, competing with WPD Pharmaceuticals in the healthcare sector.

About

WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Show More
CEO
Mariusz Olejniczak
Employees
16
Country
Canada
ISIN
CA92941F2044
WKN
000A2PX9R

Listings

STU
DE
8SV.STU
MU
DE
8SV.MU
CN
CA
WBIO.CN

0 Comments

Share your thoughts

FAQs

What is WPD Pharmaceuticals stock price today?▼
The current price of WBIO.CN is C$0.07 CAD — it has decreased by -63.16% in the past 24 hours. Watch WPD Pharmaceuticals stock price performance more closely on the chart.
What is WPD Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange WPD Pharmaceuticals stocks are traded under the ticker WBIO.CN.
What is WPD Pharmaceuticals market cap?▼
Today WPD Pharmaceuticals has the market capitalization of 8.12M
What were WPD Pharmaceuticals earnings last quarter?▼
WBIO.CN earnings for the last quarter are -0.01 CAD per share, whereas the estimation was N/A CAD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is WPD Pharmaceuticals revenue for the last year?▼
WPD Pharmaceuticals revenue for the last year amounts to 0 CAD.
What is WPD Pharmaceuticals net income for the last year?▼
WBIO.CN net income for the last year is -80,000 CAD.
How many employees does WPD Pharmaceuticals have?▼
As of November 5, 2026, the company has 16 employees.
In which sector is WPD Pharmaceuticals located?▼
WPD Pharmaceuticals operates in the Health & Wellness sector.
When did WPD Pharmaceuticals complete a stock split?▼
The last stock split for WPD Pharmaceuticals was on December 30, 2024 with a ratio of 1:25.
Where is WPD Pharmaceuticals headquartered?▼
WPD Pharmaceuticals is headquartered in Vancouver, Canada.